The potential clinical relevance of HSF1 in HCC is supported by the findings that the abolishment of HSF1 in mice overexpressing AKT, inhibited AKT-driven hepatocarcinogenesis [125]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.